Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 646,750 | 742,690 | 709,239 | 702,110 | 663,400 |
| Cost of Goods | 166,020 | 710,000 | N/A | N/A | N/A |
| Gross Profit | 480,730 | 2,114,000 | 709,239 | 702,110 | 663,400 |
| Operating Expenses | 383,630 | 1,467,570 | 27,720 | 15,910 | 39,800 |
| Operating Income | 97,120 | -1,434,880 | 681,519 | 686,200 | 623,600 |
| Interest Expense | 0 | 15,000 | 0 | 0 | 0 |
| Other Income | 52,380 | 1,627,980 | -503,559 | -524,040 | -425,820 |
| Pre-tax Income | 149,500 | 178,100 | 177,960 | 162,160 | 197,780 |
| Income Tax | N/A | 63,370 | 64,080 | 58,380 | 71,170 |
| Net Income Continuous | 97,230 | 114,750 | 112,836 | 103,770 | 126,600 |
| Net Income | $97,230 | $114,750 | $112,836 | $103,770 | $126,600 |
| EPS Basic Total Ops | N/A | N/A | 0.02 | N/A | N/A |
| EPS Basic Continuous Ops | N/A | N/A | 0.02 | N/A | N/A |
| EPS Diluted Total Ops | N/A | N/A | 0.02 | N/A | N/A |
| EPS Diluted Continuous Ops | N/A | N/A | 0.02 | N/A | N/A |
| EBITDA(a) | $97,120 | $-1,434,880 | $681,519 | $686,200 | $623,600 |